NCT07029867View on ClinicalTrials.gov

Efficacy and Safety of Yishen Daluo Yin Granule for Relapsing-Remitting Multiple Sclerosis

NANot yet recruitingINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

June 15, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions
Relapse Remitting Multiple Sclerosis
Interventions
DRUG

Yishen Daluo Yin granuls

The patient takes YSDLY granules or placebo twice a day.

DRUG

Placebo

The patient takes placebo (YSDL mimetic granules) twice a day.

All Listed Sponsors
collaborator

First Affiliated Hospital of Jinan University

OTHER

collaborator

The Second Hospital of Hebei Medical University

OTHER

collaborator

Chinese PLA General Hospital

OTHER

lead

Ying Gao

OTHER